Abstract Topics

  • Biology of ALL, AML, CML, CLL
  • Leukemia stem cells (LSCs)
  • Routing diagnosis gene expression and mutational profiling
  • Allogeneic hematopoietic stem cell transplantation
  • Front-line treatment of ALL, AML, CML, CLL
  • Treatment of resistant/relapsed disease
  • How novel agents are changing the treatment landscape of ALL, AML, CML and CLL
  • Immunotherapy
  • Minimal residual disease
  • Clinical Cases (Case) Reports
EUROLEUK will be broadcast Central European Time (CET)

Approximately one week before the Congress, all registered delegates will receive an invitation with a personal link to set their profile and enter the virtual Congress platform. Your personal link will only be valid until the end of the Congress. In order to view the Congress lectures and panel discussions, delegates must enter the virtual Congress platform and set their profile before the end of the Congress.

For assistance entering the virtual platform, please send an email to: info@bioevents-congress.com